| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Principal Accounting Officer
1 company
Piskel Kyle is a Chief Financial Officer at Adaptive Biotechnologies Corp. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $5.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 | ADPT Adaptive Biotechnologies Corp | Principal Accounting Officer | Sell | 220 | $12.01 | $2,642.20 | -0.5% | -41.9% | -26.5% |